AMINOSYN II 15% Amino Acid Injection Recalled for Particulate Matter
ICU Medical Inc is recalling AMINOSYN II 15% An Amino Acid Injection due to the presence of particulate matter including fibers, hair, and proteinaceous material found in retained samples.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class I. According to the severity rubric, FDA Class I recalls receive a minimum score of 4 (Severe), regardless of whether illnesses or injuries have been reported.
Plain-English summary
ICU Medical Inc is recalling AMINOSYN II 15% An Amino Acid Injection, Sulfite-Free, 2000 mL in flexible containers (NDC 0409-7171-17, Lot 4989094, Expiration 01-APR-2022) because particulate matter has been identified in the product. The particulate matter consists of fibers, hair, proteinaceous material, and other particles.
This product was distributed nationwide in the USA. AMINOSYN II 15% is a prescription amino acid injection used in medical settings.
Consumers and healthcare providers who have received this product should not use it. Any remaining units of the affected lot should be quarantined and not administered to patients. Healthcare facilities should contact their supplier or ICU Medical Inc for instructions on returning the product or obtaining replacement units.
The recalled product
- Product
- AMINOSYN II 15% An Amino Acid Injection, Sulfite-Free, 2000 mL in flexible containers, Rx ONLY, Hospira, Inc., Lake Forest, IL 60045. NDC 0409-7171-17
- Manufacturer
- ICU Medical Inc
- Affected units
- 2,112
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 4989094 Exp. 01-APR-2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · ICU Medical Inc
See all →- HighICU Medical Recalls Hotline Fluid Warming Sets Due to Leakage Risk
FDA (Devices) · 2026-07-29
- SevereICU Medical Plum Duo Infusion Pump Software Defect Affecting Drug Delivery
FDA (Devices) · 2026-07-22
- SevereICU Medical Plum Solo Precision IV Pump May Deliver Excess Medication
FDA (Devices) · 2026-07-22
- HighPlum Duo Precision IV pumps may not display soft limit alerts
FDA (Devices) · 2026-06-17
- HighPlum Solo Precision IV pumps may not display soft limit alerts
FDA (Devices) · 2026-06-17
Same hazard · particulate matter
See all →- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- CriticalBaxter Recalls Sodium Chloride Injection Bags Due to Fiberglass Particulates
FDA (Drugs) · 2026-09-09
- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26